Publication | Closed Access

The bivalent factor H binding protein meningococcal serogroup B vaccine elicits bactericidal antibodies against representative non-serogroup B meningococci

VaccinationVaccine DevelopmentVaccine TargetImmunologyMicrobiologyInfection ControlPolyvalent VaccineBacterial MeningitisMedicineVaccine ResearchClinical MicrobiologyVaccine DesignBactericidal Antibodies